Literature DB >> 26753843

Risk factors for bone cement leakage in percutaneous vertebroplasty: a retrospective study of four hundred and eighty five patients.

Si-Yuan Zhu1, Zhao-Ming Zhong1, Qian Wu1, Jian-Ting Chen2.   

Abstract

PURPOSE: Percutaneous vertebroplasty (PVP) is a common procedure in spine surgery. Bone cement leakage is the most common complication related to this procedure. The purpose of this study was to assess the incidence and risk factors for cement leakage after PVP.
METHODS: A total of 485 patients who underwent PVP between August 2003 and August 2013 were enrolled in the study. Clinical and radiological characteristics, including age, gender, diagnosis, operated level, surgical approach, type of anesthesia, volume of bone cement, fracture type, and fracture severity, were considered as potential risk factors. Cement leakage was assessed based on post-operative imaging examination. Six types of leakage were defined and risk factors for each type were analyzed.
RESULTS: The incidence of leakage was 58.2 %. Binary logistic analysis revealed that larger volume of bone cement (P < 0.001) and higher fracture severity grade (P < 0.001) were the strongest independent risk factors. Univariate analysis and multinomial logistic analysis showed that surgical approach (P < 0.001), gender (P = 0.016), and operated level (P = 0.032) were additional risk factors for leakage. Further analysis showed that more bone cement was used in bilateral than unilateral approaches, that men had larger volumes of bone cement injected than women, and that more bone cement was injected into lumbar vertebrae than thoracic vertebrae. Therefore, these risk factors (surgical approach, gender, and operated level) could be attributed to excess bone cement usage.
CONCLUSIONS: Cement leakage is very common with PVP. Higher fracture severity grade and larger volume of bone cement were the two strongest independent risk factors for leakage.

Entities:  

Keywords:  Cement leakage; Complications; Percutaneous vertebroplasty; Risk factor; Vertebral compression fracture

Mesh:

Substances:

Year:  2016        PMID: 26753843     DOI: 10.1007/s00264-015-3102-2

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  28 in total

1.  Height restoration and maintenance after treating unstable osteoporotic vertebral compression fractures by cement augmentation is dependent on the cement volume used.

Authors:  Antonio Krüger; Gamal Baroud; David Noriega; Jens Figiel; Christine Dorschel; Steffen Ruchholtz; Ludwig Oberkircher
Journal:  Clin Biomech (Bristol, Avon)       Date:  2013-07-19       Impact factor: 2.063

2.  Cement leakage in percutaneous vertebroplasty for osteoporotic vertebral compression fractures: identification of risk factors.

Authors:  Marc J Nieuwenhuijse; Arian R Van Erkel; P D Sander Dijkstra
Journal:  Spine J       Date:  2011-09-01       Impact factor: 4.166

3.  Pain reduction following vertebroplasty and kyphoplasty.

Authors:  Renbin Dong; Liang Chen; Tiansi Tang; Yong Gu; Zongping Luo; Qin Shi; Xuefeng Li; Qingsheng Zhou; Huilin Yang
Journal:  Int Orthop       Date:  2012-11-11       Impact factor: 3.075

4.  Dose-dependent epidural leakage of polymethylmethacrylate after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures.

Authors:  Kyung Sik Ryu; Chun Kun Park; Moon Chan Kim; Joon Ki Kang
Journal:  J Neurosurg       Date:  2002-01       Impact factor: 5.115

5.  A clinical comparative study on low versus medium viscosity polymethylmetacrylate bone cement in percutaneous vertebroplasty: viscosity associated with cement leakage.

Authors:  Marc J Nieuwenhuijse; Sander P J Muijs; Arian R van Erkel; Sander P D Dijkstra
Journal:  Spine (Phila Pa 1976)       Date:  2010-09-15       Impact factor: 3.468

6.  Percutaneous treatment of vertebral compression fractures: a meta-analysis of complications.

Authors:  Michael J Lee; Mark Dumonski; Patrick Cahill; Tom Stanley; Daniel Park; Kern Singh
Journal:  Spine (Phila Pa 1976)       Date:  2009-05-15       Impact factor: 3.468

7.  Vertebroplasty: experimental characterization of polymethylmethacrylate bone cement spreading as a function of viscosity, bone porosity, and flow rate.

Authors:  Mario Loeffel; Stephen J Ferguson; Lutz-P Nolte; Jens H Kowal
Journal:  Spine (Phila Pa 1976)       Date:  2008-05-20       Impact factor: 3.468

8.  Treatment of multiple osteoporotic vertebral compression fractures by percutaneous cement augmentation.

Authors:  Agnieszka Saracen; Zbigniew Kotwica
Journal:  Int Orthop       Date:  2014-08-09       Impact factor: 3.075

9.  [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty].

Authors:  P Galibert; H Deramond; P Rosat; D Le Gars
Journal:  Neurochirurgie       Date:  1987       Impact factor: 1.553

10.  Asymptomatic bone cement pulmonary embolism after vertebroplasty: case report and literature review.

Authors:  Girolamo Geraci; Giorgio Lo Iacono; Chiara Lo Nigro; Fabio Cannizzaro; Massimo Cajozzo; Giuseppe Modica
Journal:  Case Rep Surg       Date:  2013-05-07
View more
  33 in total

1.  Risk factors of recompression of cemented vertebrae after kyphoplasty for osteoporotic vertebral compression fractures.

Authors:  Dapeng Li; Yan Wu; Yonghui Huang; Balaara Augustine; Jiawei Yue
Journal:  Int Orthop       Date:  2016-04-27       Impact factor: 3.075

2.  SPINAL SPECIAL EDITION EDITORIAL.

Authors:  Andrew Quaile
Journal:  Int Orthop       Date:  2016-06       Impact factor: 3.075

3.  The cement leakage in cement-augmented pedicle screw instrumentation in degenerative lumbosacral diseases: a retrospective analysis of 202 cases and 950 augmented pedicle screws.

Authors:  Hui-Zhi Guo; Yong-Chao Tang; Dan-Qing Guo; Shun-Cong Zhang; Yong-Xian Li; Guo-Ye Mo; Pei-Jie Luo; Ten-Peng Zhou; Yan-Huai Ma; Xiao-Bing Jiang
Journal:  Eur Spine J       Date:  2019-04-27       Impact factor: 3.134

4.  Precise puncture combined with simplified percutaneous vertebroplasty to treat osteoporotic vertebral compression fractures: a comparative analysis with conventional percutaneous vertebroplasty.

Authors:  Jutao Pang; Bin Liu; Hong Chen; Wei Zhang; Jianhua Sun; Xinhu Zhang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

5.  A Nomogram to Predict Intra-Spinal Canal Cement Leakage Among Elderly Patients with Spine Metastases: An Internal-Validated Model.

Authors:  Xuedong Shi; Yunpeng Cui; Yuanxing Pan; Bing Wang; Mingxing Lei
Journal:  Clin Interv Aging       Date:  2021-09-29       Impact factor: 4.458

6.  Epidemiology and detection of cement leakage in patients with spine metastases treated with percutaneous vertebroplasty: A 10-year observational study.

Authors:  Xuedong Shi; Yunpeng Cui; Yuanxing Pan; Bing Wang; Mingxing Lei
Journal:  J Bone Oncol       Date:  2021-05-01       Impact factor: 4.072

7.  Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study.

Authors:  Xianglin Hu; Wending Huang; Zhengwang Sun; Hui Ye; Kwong Man; Qifeng Wang; Yangbai Sun; Wangjun Yan
Journal:  EPMA J       Date:  2022-01-10       Impact factor: 6.543

Review 8.  Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis.

Authors:  Min Zhuang; Bin Cai; Fanfan Wang
Journal:  Arch Orthop Trauma Surg       Date:  2021-03-13       Impact factor: 2.928

9.  Is It Necessary to Approach the Severe Osteoporotic Vertebral Biconcave-Shaped Fracture Bilaterally During the Process of PKP?

Authors:  Bing Tan; Qi-Yuan Yang; Bin Fan; Chao Lei; Zhen-Ming Hu
Journal:  J Pain Res       Date:  2021-06-04       Impact factor: 3.133

10.  Stentoplasty with Resorbable Calcium Salt Bone Void Fillers for the Treatment of Vertebral Compression Fracture: Evaluation After 3 Years.

Authors:  Mengmeng Chen; Ruideng Wang; Pu Jia; Li Bao; Hai Tang
Journal:  Clin Interv Aging       Date:  2021-05-17       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.